You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 6, June 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neurogenetics
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
The Need for Appropriate Genotyping Strategies for Glucocerebrosidase Mutations in Cohorts With Parkinson Disease

Usha Gutti, MS; Hon-Chung Fung, MD; Kathleen S. Hruska, PhD; Mary E. LaMarca, BS; Chiung-Mei Chen, MD, PhD; Yih-Ru Wu, MD; Ellen Sidransky, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Tan et al1 reporting mutations in the glucocerebrosidase gene (GBA) in Chinese patients with Parkinson disease (PD) is the third recent article in series of patients of Chinese ancestry.1-3 These studies are important because they support the previously described association of GBA mutations and parkinsonism in white and Ashkenazi Jewish PD cohorts4-5 in a population that is clearly of non–Ashkenazi Jewish ancestry.

Tan and colleagues chose to screen for only 2 GBA mutations, L444P and N370S. While both of these mutations are relatively common in white and Ashkenazi Jewish populations, the N370S mutation has not been reported in Asian patients with Gaucher disease.6 Thus, the frequency of GBA mutations reported in this article, 2.4%, is likely to be a vast underestimate.

. . . [Full Text of this Article]

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Glucocerebrosidase Mutations and Risk of Parkinson Disease in Chinese Patients
Eng-King Tan, Justina Tong, Stephanie Fook-Chong, Yuen Yih, Meng-Cheong Wong, Ratnagopal Pavanni, and Yi Zhao
Arch Neurol. 2007;64(7):1056-1058.
EXTRACT | FULL TEXT  

The Need for Appropriate Genotyping Strategies for Glucocerebrosidase Mutations in Cohorts With Parkinson Disease—Reply
Eng-King Tan
Arch Neurol. 2008;65(6):851.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Glucocerebrosidase Mutations and Risk of Parkinson Disease in Chinese Patients
Eng-King Tan, Justina Tong, Stephanie Fook-Chong, Yuen Yih, Meng-Cheong Wong, Ratnagopal Pavanni, and Yi Zhao
Arch Neurol. 2007;64(7):1056-1058.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.